MedTrace Logo

Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry Eye

NCT03012698 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2019-11-25

No results posted yet for this study

Summary

The study aims to test the safety of Repetitive Magnetic Stimulation (RMS) treatment for dry eye disease. Patients are asked to undergo a one-time treatment with Epitech Ocular Magnetic Stimulation Device on one eye in the first stage and both eyes sequentially in the second stage of the study. Changes are monitored for over a study period of 3 months.

Conditions

  • Dry Eye
  • Sjogren's Syndrome
  • Aqueous Tear Deficiency
  • Meibomian Gland Dysfunction
  • Dry Eye Syndromes

Interventions

DEVICE

Ocular Repetitive Magnetic Stimulation (RMS) treatment

First stage: Patients will be asked to undergo a one-time treatment with Epitech Corneal Magnetic Stimulation Device on one eye. The worst eye will be treated; if both eyes are equal, the right eye will be treated. Second stage: will be treated on both eyes, applying treatment to both eyes sequentially during the same visit.

Sponsors & Collaborators

  • Epitech Mag Ltd.

    lead INDUSTRY

Principal Investigators

  • Avi Solomon, MD · Hadassah Medical Organization

  • David Zadok, MD · Shaare Zedek Medical Center

  • Haggay Avizemer, MD · Wolfson Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2019-06-17
Completion
2019-06-17

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03012698 on ClinicalTrials.gov